Influence of different benzodiazepines on the experimental morphine abstinence syndrome
- PMID: 1686654
- DOI: 10.1007/BF02244309
Influence of different benzodiazepines on the experimental morphine abstinence syndrome
Abstract
The abuse of benzodiazepines by narcotic addicts has been well documented. However, the pharmacological basis of this abuse is not clear. In this study the effects of different benzodiazepines (flunitrazepam: 0.5, 1 and 2 mg/kg; nitrazepam: 0.5, 1, 2.5, 5 and 10 mg/kg; diazepam: 0.5, 1, 2.5, 5 and 10 mg/kg; chlordiazepoxide: 0.5, 1, 2.5, 5 and 10 mg/kg; and triazolam: 0.5, 1 and 2 mg/kg) on the morphine withdrawal syndrome in mice have been compared. Drugs were administered 30 min before naloxone-induced withdrawal. All benzodiazepines tested induced similar changes in some of the signs of morphine abstinence: decreased jumping behavior and increased wet dog shake frequency. Jumping behavior was particularly decreased by triazolam and wet dog shakes were mainly increased by flunitrazepam and nitrazepam. Forepaw treading was reduced by flunitrazepam, diazepam and triazolam, increased by nitrazepam and not changed by chlordiazepoxide. Tremor was effectively reduced by diazepam but less reliably by the other benzodiazepines. Teeth chattering was reduced by flunitrazepam and diazepam. These results indicate that benzodiazepines can interfere with the expression of the morphine withdrawal syndrome.
Similar articles
-
Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome.Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(6):927-33. doi: 10.1016/0278-5846(88)90089-9. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 3241876
-
Effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats.J Pharmacol Exp Ther. 1979 Jan;208(1):63-6. J Pharmacol Exp Ther. 1979. PMID: 32386
-
Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.Behav Pharmacol. 2018 Aug;29(5):393-399. doi: 10.1097/FBP.0000000000000376. Behav Pharmacol. 2018. PMID: 29462108
-
Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.NIDA Res Monogr. 1995;147:170-81. NIDA Res Monogr. 1995. PMID: 8742786 Review.
-
Animal models of drug withdrawal symptoms.Psychopharmacology (Berl). 1990;101(3):292-309. doi: 10.1007/BF02244046. Psychopharmacology (Berl). 1990. PMID: 1972994 Review.
Cited by
-
Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.Psychopharmacology (Berl). 1996 Jan;123(1):64-70. doi: 10.1007/BF02246282. Psychopharmacology (Berl). 1996. PMID: 8741956
-
Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.Eur J Pharmacol. 2008 Mar 31;583(1):48-55. doi: 10.1016/j.ejphar.2008.01.004. Epub 2008 Jan 24. Eur J Pharmacol. 2008. PMID: 18275956 Free PMC article.
-
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.Psychopharmacology (Berl). 2005 Apr;178(4):353-66. doi: 10.1007/s00213-005-2155-0. Epub 2005 Feb 5. Psychopharmacology (Berl). 2005. PMID: 15696323 Review.
-
Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.Br J Pharmacol. 2005 Aug;145(7):975-83. doi: 10.1038/sj.bjp.0706247. Br J Pharmacol. 2005. PMID: 15912139 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources